A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer (Q46706272)
Jump to navigation
Jump to search
scientific article published in September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer |
scientific article published in September 2005 |
Statements
1 reference
A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer (English)
1 reference
George Wilding
1 reference
Constantin Yiannoutsos
1 reference
Christopher Sweeney
1 reference
Glenn Liu
1 reference
Jill Kolesar
1 reference
Dorothea Horvath
1 reference
Mary Jane Staab
1 reference
Karen Fife
1 reference
Victoria Armstrong
1 reference
Anthony Treston
1 reference
Carolyn Sidor
1 reference
1 September 2005
1 reference
11
1 reference
18
1 reference
6625-6633
1 reference